Natura-Alpha Targets Forkhead Box M1 and Inhibits Androgen-Dependent and -Independent Prostate Cancer Growth and Invasion - Concepedia

Concepedia

Publication | Open Access

Natura-Alpha Targets Forkhead Box M1 and Inhibits Androgen-Dependent and -Independent Prostate Cancer Growth and Invasion

DOI Full Paper Access

40

Citations

31

References

2011

Year

Yirong Li, Martin Ligr, James P. McCarron, Garrett Daniels, David Zhang, Xin Zhao, Fei Ye, Jinhua Wang, Xiaomei Liu, Iman Osman,

Clinical Cancer Research

Abstract

Natura-alpha could serve as a novel and effective therapeutic agent for treatment of both hormone-sensitive and hormone-refractory PC with minimal side effects.

References

	Year	Citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, JNCI Journal of the National Cancer Institute World Health OrganizationSolid TumorsCancer ManagementMetronomic ChemotherapyResponse Assessment	2000	15.7K
Cancer Statistics, 2010 Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu, CA A Cancer Journal for Clinicians	2010	12.6K
FoxM1 is required for execution of the mitotic programme and chromosome stability Jamila Laoukili, Matthijs R. H. Kooistra, Alexandra Le Bras, Nature Cell Biology Mitotic ProgrammeChromatinGenome InstabilityChromosome StabilityChromatin Structure	2005	812
Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design Ting‐Chao Chou, Robert J. Motzer, Yanli Tong, JNCI Journal of the National Cancer Institute	1994	523
American Society of Health-System Pharmacists Edward H Lee The SAGE Encyclopedia of Pharmacology and Society Health PolicyPharmaceutical PracticeClinical PharmacyAmerican SocietyPharmaceutical Care	2016	511
Application of Mesothelin Immunostaining in Tumor Diagnosis Nelson G. Ordóǹez The American Journal of Surgical Pathology Immunocytochemical TechniqueTumor DiagnosisHistopathologyImmunologyPathology	2003	378
ATP-site Directed Inhibitors of Cyclin-dependent Kinases Nathanael G ray, Lena'lck Detivaud, Christian Doerig, Current Medicinal Chemistry Cdk InhibitorsMedicinal ChemistryDrug TargetBiochemistryCyclin-dependent Kinases Trigger	1999	271
Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators Michael L. Major, Rita Lepe, Robert H. Costa Molecular and Cellular Biology	2004	267
Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1 Senthil K. Radhakrishnan, Uppoor G. Bhat, Douglas E. Hughes, Cancer Research	2006	236
N-Cadherin Expression in Human Prostate Carcinoma Cell Lines Nhan L. Tran, Raymond B. Nagle, Anne E. Cress, American Journal Of Pathology MedicineCell-matrix InteractionN-cadherin ExpressionProstatic DiseaseCancer Biology	1999	232

Page 1